◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK: 818686 SIC: 2834
$16.78B
Revenue
$712.00M
Net Income
50.10%
Gross Margin
10.89%
Op. Margin
$578.00M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 8 annual reports available (2017 - 2024)
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
+ Total Revenue $16.78B $16.54B $15.85B $14.93B $15.88B $16.66B
Revenue Growth % 1.4% 4.4% 6.2% -6.0% -4.7% nan%
Cost of Revenue $8.37B $8.48B $8.20B $7.95B $8.28B $8.93B
+ Gross Profit $8.40B $8.06B $7.64B $6.97B $7.59B $7.73B
Gross Margin % 50.1% 48.7% 48.2% 46.7% 47.8% 46.4%
+ Operating Income $1.83B $-303.00M $433.00M $-2.10B $1.72B $-3.57B
Operating Margin % 10.9% -1.8% 2.7% -14.1% 10.8% -21.4%
Interest Expense - $1.00B $1.08B $948.00M $913.00M $846.00M
Other Income/Expense $-932.00M $-981.00M $-1.06B $-966.00M $-1.06B $-834.00M
Income Before Tax $896.00M $-1.28B $-624.00M $-3.06B $658.00M $-4.41B
Income Tax Expense $238.00M $676.00M $-7.00M $-638.00M $211.00M $-168.00M
+ Net Income $712.00M $-1.64B $-559.00M $-2.35B $417.00M $-3.99B
Net Margin % 4.2% -9.9% -3.5% -15.8% 2.6% -24.0%
Basic EPS 0.63 -1.45 -0.50 -2.12 0.38 -3.64
Diluted EPS 0.60 -1.45 -0.50 -2.12 0.38 -3.64
Basic Shares Outstanding 1.15B 1.13B 1.12B 1.11B 1.10B 1.09B
Diluted Shares Outstanding 1.16B 1.13B 1.12B 1.11B 1.11B 1.09B
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Cash & Cash Equivalents $3.30B $3.23B $2.80B $2.17B $2.18B
Accounts Receivable $3.06B $3.41B $3.70B $4.53B $4.58B
Inventory $3.01B $4.02B $3.83B $3.82B $4.40B
Other Current Assets $409.00M $504.00M $549.00M $965.00M $710.00M
Total Current Assets $12.55B $12.48B $12.05B $12.57B $13.01B
Property Plant & Equipment $4.58B $5.75B $5.74B $5.98B $6.30B
Goodwill $15.15B $17.18B $17.63B $20.04B $20.62B
Intangible Assets $4.42B $5.39B $6.27B $7.47B $8.92B
Other Non-current Assets $462.00M $470.00M $441.00M $515.00M $538.00M
Total Assets $39.33B $43.48B $44.01B $47.67B $50.64B
Short-term Debt $1.78B $1.67B $2.11B $1.43B $3.19B
Other Current Liabilities $1.02B $1.06B $1.00B $903.00M $933.00M
Total Current Liabilities $12.80B $12.25B $11.47B $11.03B $13.16B
Other Non-current Liabilities $4.03B $4.02B $3.85B $2.58B $2.24B
Total Liabilities $33.61B $35.35B $35.31B $36.42B $39.58B
Common Stock $58.00M $57.00M $57.00M $57.00M $57.00M
Retained Earnings $-15.17B $-13.53B $-12.88B $-10.53B $-10.95B
Treasury Stock $4.13B $4.13B $4.13B $4.13B $4.13B
Total Stockholders Equity $5.37B $7.51B $7.90B $10.28B $10.03B
Total Liabilities & Equity $39.33B $43.48B $44.01B $47.67B $50.64B
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Net Income $927.00M $-1.64B $-559.00M $-2.35B $417.00M $-3.99B
Depreciation & Amortization $1.26B $1.06B $1.15B $1.31B $1.33B $1.56B
Stock-based Compensation $174.00M $123.00M $121.00M $124.00M $119.00M $129.00M
Change in Working Capital $1.84B $435.00M $72.00M $-1.26B $1.70B $2.19B
Change in Inventory - $166.00M $-147.00M $-163.00M $380.00M $41.00M
Operating Cash Flow $1.07B $1.25B $1.37B $1.59B $798.00M $1.22B
Capital Expenditure $488.00M $498.00M $526.00M $548.00M $562.00M $578.00M
Acquisitions - $15.00M - $7.00M - -
Investing Cash Flow $774.00M $792.00M $968.00M $656.00M $1.52B $863.00M
Debt Repayment $6.17B $1.64B $4.15B $1.37B $6.65B $1.87B
Financing Cash Flow $-2.87B $-1.79B $-1.91B $-1.49B $-2.17B $-1.89B
Net Change in Cash $-2.72B $74.00M $393.00M $636.00M $21.00M $202.00M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $4.48B - $12.55B -
Cost of Revenue $2.18B - $6.26B -
Gross Profit $2.30B - $6.28B -
Operating Income $882.00M - $1.86B -
Other Income/Expense $-237.00M - $-714.00M -
Income Before Tax $646.00M - $1.14B -
Income Tax Expense $214.00M - $210.00M -
Net Income $433.00M - $930.00M -
Basic EPS 0.38 - 0.81 -
Diluted EPS 0.37 - 0.80 -
Basic Shares Outstanding $1.15B - $1.14B -
Diluted Shares Outstanding $1.16B - $1.16B -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $2.20B $3.30B
Accounts Receivable $3.81B $3.06B
Inventory $3.32B $3.01B
Other Current Assets $477.00M $409.00M
Total Current Assets $12.74B $12.55B
Property Plant & Equipment $4.82B $4.58B
Goodwill $15.95B $15.15B
Intangible Assets $3.94B $4.42B
Other Non-current Assets $444.00M $462.00M
Total Assets $39.86B $39.33B
Short-term Debt $24.00M $1.78B
Other Current Liabilities $1.10B $1.02B
Total Current Liabilities $11.49B $12.80B
Other Non-current Liabilities $3.66B $4.03B
Total Liabilities $32.60B $33.61B
Common Stock $58.00M $58.00M
Retained Earnings $-14.24B $-15.17B
Treasury Stock $4.13B $4.13B
Total Stockholders Equity $7.25B $5.37B
Total Liabilities & Equity $39.86B $39.33B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $433.00M - $930.00M -
Depreciation & Amortization $249.00M - $742.00M -
Stock-based Compensation $34.00M - $106.00M -
Change in Working Capital $561.00M - $1.59B -
Operating Cash Flow $369.00M - $491.00M -
Capital Expenditure $136.00M - $359.00M -
Acquisitions - - - -
Investing Cash Flow $135.00M - $572.00M -
Debt Repayment $444.00M - $4.11B -
Financing Cash Flow $-453.00M - $-2.19B -
Net Change in Cash $42.00M - $-1.10B -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...